ALSPW Spineway SA

0.1020USD0.0930 EUR · EPA-1.69%Mkt Cap: 3.63M USDP/E: —

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis…

Key Statistics

Company
Market Cap3.63M USD
Enterprise Value3.69M USD
Revenue (TTM)14.40M USD
Gross Profit9.88M USD
Net Income (TTM)-2.45M USD
Revenue/Share0.40 USD
Last Price0.1020 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees46
CountryFR
SectorHealthcare
IndustryMedical Instruments & Supplies
ISINFR001400N2P2
Valuation
P/E (Trailing)—
P/E (Forward)-1.55
PEG—
EV/EBITDA-1.43
EV/Revenue0.26
P/S0.25
P/B0.15
EPS (TTM)-0.07 USD
EPS (Forward)-0.07 USD
52W Range
0.08959% of range0.2314
52W High0.2314 USD
52W Low0.0895 USD
Profitability
Gross Margin72.48%
Oper. Margin-20.08%
EBITDA Margin-18.00%
Profit Margin-18.00%
ROE-9.71%
ROA-7.60%
ROIC-7.15%
ROCE-6.43%
Growth
Revenue Growth5.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF-178.78K USD
CapEx (TTM)—
FCF Margin-7.81%
FCF Yield-31.00%
Net Debt68.00K USD
Net Debt/EBITDA-0.03
Net Debt/FCF—
Balance Sheet
Debt/Equity0.07
Current Ratio1.91
Quick Ratio0.98
Book Value/Sh0.66 USD
Cash/Share0.04 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:2000
Split DateFeb 27, 2024
Analyst Consensus
Rating—
Target (Mean)0.2303 USD
Upside (mean)+125.8%
Target Range0.2303 USD – 0.2303 USD
# Analysts1
Ownership
Shares Out.35.54M
Float—
Insiders0.00%
Institutions0.00%
Technical
SMA 500.1138 (-10.3%)
SMA 2000.1459 (-30.1%)
Beta0.23
S&P 52W Chg12.00%
Avg Vol (30d)111.57K
Avg Vol (10d)40.08K
Technical Indicators
RSI (14)44.4
MACD-0.0024
MACD Signal-0.0034
MACD Hist.+0.0009
BB Upper0.1101 USD
BB Middle0.1019 USD
BB Lower0.0938 USD
BB Width15.94%
ATR (14)0.0074 USD
Vol Ratio (20d)0.90x

About Spineway (EPA: ALSPW)

›

Spineway (EPA: ALSPW) is listed on Euronext Paris, where its shares trade in EUR. It belongs to the Medical Instruments & Supplies industry, part of the Healthcare sector, and reports about 46 employees.

The shares were at 0.0930 EUR on 19 November 2026, down 43.6% over 52 weeks. Its 52-week range is 0.0816 EUR to 0.2110 EUR: the price is 55.9% below the high and 14.0% above the low.

Its market capitalisation is 3.31M EUR.

Spineway reports return on equity of -9.7%, an operating margin of -20.1% and revenue up 5.5% year over year.

Its debt exceeds its cash by 62.00K EUR, a debt-to-equity ratio of 0.07. Its Piotroski F-score is 5 out of 9, an average reading of its financial health. One analyst covers the stock; their mean price target of 0.2100 EUR is 125.8% above the current price.